Navigation Links
Echo Therapeutics Announces First Quarter 2013 Financial Results
Date:5/10/2013

dministration expenses were $2.3 million for the first quarter of 2013 versus $1.9 million in the prior year. The Company reported a cash balance of approximately $5.2 million as of March 31, 2013.Conference Call
Management will host a conference call today starting at 9:00 AM EDT.  To listen in and/or participate in the call, please dial (877) 317-6789 and reference the conference number 10028680.  The archived audiocast will be available for fourteen days following the call by visiting the Events section of Echo's website at www.echotx.com.

About Echo Therapeutics
Echo Therapeutics is developing the Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system.  Our target is patients who could benefit from glucose monitoring in the hospital setting, including critical care.  Significant opportunity also exists for patients with diabetes to use Symphony in the outpatient setting.  Echo is also developing its needle-free skin preparation component of Symphony, the Prelude® SkinPrep System, as a platform technology to enhance drug delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking StatementsThe statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the safety and efficacy of Echo's Symphony CGM System, the failure of future development and preliminary marketing efforts related to Echo's Symphony CGM System, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties rela
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ ... into non-exclusive Development Agreements with Dexcom, Inc. to ... pumps with the Dexcom G5 and G6 continuous ... next generation pump platform with Dexcom,s future CGM ...
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... SOUTH PLAINFIELD, N.J., July 30, 2015 PTC ... corporate update and reported financial results for the second ... is progressing on many fronts across the organization.  We ... largest Duchenne muscular dystrophy clinical trial ever conducted with ... W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... , , , , ... this month, dog owners in the Midwest will find that getting their ... the Mobile Dog Heart Health Tour will make stops with a sound-proof ... in Chicago on August 30 to perform free dog heart examinations. , ...
... REHOVOT, Israel, August 17 D-Pharm ... 85 million (approximately,$23M USD) to fund the Company,s late stage ... NIS 57 million and an Initial,Public Offering (IPO) of NIS ... set at 133 NIS, 13% higher than the minimum price. ...
Cached Medicine Technology:Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations 2Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations 3D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 2D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 3
(Date:8/1/2015)... ... ... Calvary Hospital today announced that it is embarking on a yearlong restoration of ... this Torah – dating from 1880 – back to kosher status, so that it ... No. 515, from the town of Taus-Domazlice, is on permanent loan to Calvary from ...
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of ... unification of their Healthy Home mission with the HOPE Movement of EvolvHealth. In what ... of both companies have agreed to join their missions of purpose together to change ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, ... who are thought to have been behind the attack on Anthem Inc. which resulted ... zero day exploits, watering hole attacks and spear phishing campaigns. , For ...
(Date:8/1/2015)... ... 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair Care, ... small business donation to kick off the campaign for healing and Well-Being. , BeverlyD ... a complete line of raw, organic hair care products, as well as her book, ...
(Date:8/1/2015)... ... 2015 , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community ... by stepping off Springer Mountain and heading north. Since that day, Phil has hiked ... and was greeted by friends and family. He visited CCAR and left an inspirational ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... Thoratec Corporation,(Nasdaq: THOR ), a world leader ... restore failing hearts, today said that,revenues for fiscal 2008 ... For the year ended January ... revenues of $234.8 million in fiscal 2007. Revenues for,the ...
... Positive Operating Cash Flow in Fourth QuarterSAN DIEGO, Feb. 5 ... BioZ(R) Impedance Cardiography (ICG) technology, today reported financial results for its ... Results for Fourth Quarter 2008 Compared with Fourth Quarter 2007 , ... Net ICG sales increased 6% to $6.5 million, up from $6.2 ...
... can affect learning in children , , THURSDAY, Feb. 5 ... may affect their children,s memory and the severity of ... brain function of pre-adolescent mice with a genetically engineered ... the mice were given two weeks of exposure to ...
... problems, study finds , , THURSDAY, Feb. 5 (HealthDay News) -- ... toxic dust after the Sept. 11, 2001, terror attack in ... new study finds. , The rate of problems is much ... expected in people who smoke, said study co-author Dr. Jacqueline ...
... Calif., Feb. 5 Cepheid (Nasdaq: CPHD ) ... $37.8 million. Net loss was $5.9 million, or $(0.10) ... a net loss of $5.3 million, or $(0.10) per share, ... of purchased intangible assets and stock compensation expenses, non-GAAP net ...
... 5 Impersonating nurses in a,multimillion dollar campaign ... to a phony RN group, and the diversion ... Employees International Union has,sharply escalated an offensive to ... California Nurses Association/NNOC charged today. , ...
Cached Medicine News:Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 2Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 3Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 4Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 5Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 6Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 7Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 8Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 9Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 10Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 11Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 12Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 13Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 14Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 15Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 16Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 17Health News:Thoratec Reports 34 Percent Increase in 2008 Revenues 18Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 2Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 3Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 4Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 5Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 6Health News:CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008 7Health News:What Moms Learned May Be Passed to Offspring 2Health News:Lung Problems Persist for 9/11 Responders 2Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 2Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 3Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 4Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 5Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 6Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 7Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 8Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 9Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 10Health News:Cepheid Reports Fourth Quarter and Full Year 2008 Results 11
... specifically designed to work with the EC120 ... a small tank blotter that incorporates the ... buffer requirements and fast transfer rates), with ... blotting such as arcing and buffer depletion. ...
... The XCell II Blot Module allows you to ... to membranes. It fits neatly into the XCell ... the gel/buffer core assembly. It requires less than ... and northern transfers. Tough platinized titanium and stainless ...
... The GENIE is the proven electrophoretic transfer ... ultimate in field uniformity. Its design allows ... electrodes which, when coupled with a low ... charger, creates a high field in volts/cm. ...
Semi-Dry Blotting Unit for 10 x 10cm Gels...
Medicine Products: